Rifaximin-a for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Mads Israelsen; Bjørn Stæhr Madsen; Nikolaj Torp; Stine Johansen; Camilla Dalby Hansen; Sönke Detlefsen; Peter Andersen; Johanne Kragh Hansen; Katrine Prier Lindvig; Ditlev Nytoft Rasmussen; Katrine Holtz Thorhauge; Maria Kjærgaard; Morten Karsdal; Torben Hansen; Manimozhiyan Arumugam; Jonel Trebicka; Maja Thiele and Aleksander Krag

Journal title: Lancet Gastroenterol Hepatol

Journal publisher: The Lancet Publishing Group

Published year: 2023

DOI identifier: 10.1016/s2468-1253(23)00010-9

ISSN: 0140-6736